Celiac.com 12/12/2018 - In a step that health officials say could provide immediate relief to the estimated eight million Indians who suffer from celiac disease, the Indian government is assessing a plan to require drugmakers to declare any gluten ingredients on medical labels.
India’s chief drug advisory body will discuss the issue at its meeting scheduled in early December, said people with knowledge of the plan. The Drug Technical Advisory Board’s decision to address the issue of gluten-free labels for drugs and medicine comes on the heels of an active recommendation by the department of physical medicine and rehabilitation at the All India Institute of Medical Sciences (AIIMS).
Celiac.com Sponsor (A12):
In addition to clear gluten-warnings on all medical labels, experts at AIIMS have proposed changing the law to force drug makers to actively avoid gluten-containing ingredients in drugs or medicine. The proposal aligns with guidelines drafted by the US Food and Drug Administration (FDA) in 2017. Those guidelines call for drug makers to properly label medications that contain gluten. The FDA also recommends that drug makers include a voluntary statement that indicates that the product contains no gluten, or any ingredient made from wheat, barley, or rye.
Proper labeling of drugs and medicines is getting a great deal of attention from regulatory bodies over the last couple of years. Look for that trend to continue and for new guidelines to drive new labeling practices for medicines containing gluten ingredients. Overall, this is an extremely positive development for anyone with celiac disease or a medical gluten-sensitivity.
Until such new guidelines make it to the pharmacy, be sure to check with your pharmacist about any drug or medicine you think might contain gluten. They are in a strong position to help, and can usually get answers to such questions.
Lastly, stay tuned for more news on the official labeling decision by India's Drug Technical Advisory Board.
Read more at: LIVEMINT.COM
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now